During the past decade, St. Vincent Heart Center of Indiana conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 33 clinical trials were completed, i.e. on average, 103.1% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 16 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Vincent Heart Center of Indiana" #1 sponsor was "Boston Scientific Corporation" with 11 trials, followed by "Abbott Medical Devices" with 10 trials sponsored, "Edwards Lifesciences" with 10 trials sponsored, "Medtronic Cardiovascular" with 6 trials sponsored and "Bolton Medical" with 6 trials sponsored. Other sponsors include 38 different institutions and companies that sponsored additional 39 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Vincent Heart Center of Indiana" #1 collaborator was "Bristol-Myers Squibb" with 3 trials as a collaborator, "Daiichi Sankyo, Inc." with 3 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "Boston Scientific Corporation" with 2 trials as a collaborator and "Medtronic" with 2 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "St. Vincent Heart Center of Indiana" are "Coronary Artery Disease" (24 trials), "Aortic Stenosis" (5 trials), "Aortic Valve Stenosis" (5 trials), "Atrial Fibrillation" (5 trials) and "Coronary Artery Stenosis" (4 trials). Many other conditions were trialed in "St. Vincent Heart Center of Indiana" in a lesser frequency.

Most popular intervention types in "St. Vincent Heart Center of Indiana" are "Device" (71 trials), "Drug" (16 trials), "Procedure" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)" (4 trials), "TAXUS Liberté-SR" (3 trials), "Placebo" (2 trials), "Surgical Aortic Valve Replacement (SAVR)" (2 trials) and "TAVR" (2 trials). Other intervention names were less common.

The vast majority of trials in "St. Vincent Heart Center of Indiana" are 83 trials for "All" genders.

Currently, there are NaN active trials in "St. Vincent Heart Center of Indiana". undefined are not yet recruiting, 8 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 49 completed trials in St. Vincent Heart Center of Indiana, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in St. Vincent Heart Center of Indiana, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 47 trials that are defined as “Not Applicable".